• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗乳腺癌危险因素的系统评价和荟萃分析。

Breast cancer risk factors in Iran: a systematic review & meta-analysis.

机构信息

Department of Medical Laboratory Sciences, Student Research Committee, School of Allied Medical Science, Mazandaran University of Medical Sciences, Sari, Islamic Republic of Iran.

Gastrointestinal Cancer Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Islamic Republic of Iran.

出版信息

Horm Mol Biol Clin Investig. 2020 Oct 21;41(4):/j/hmbci.ahead-of-print/hmbci-2020-0021/hmbci-2020-0021.xml. doi: 10.1515/hmbci-2020-0021.

DOI:10.1515/hmbci-2020-0021
PMID:33079703
Abstract

OBJECTIVES

Breast cancer is known as one of the deadliest forms of cancer, and it is increasing globally. There are a variety of proven and controversial risk factors for this malignancy. Herein, we aimed to undertake a systematic review and meta-analysis focus on the epidemiology of breast cancer risk factors in Iran.

METHODS

We performed a systematic search via PubMed, Scopus, Web of Science, and Persian databases for identifying studies published on breast cancer risk factors up to March 2019. Meta-analyses were done for risk factors reported in more than one study. We calculated odds ratios (ORs) with corresponding 95% confidence intervals (CIs) using a fixed/random-effects models.

RESULTS

Thirty-nine studies entered into the meta-analysis. Pooling of ORs showed a significant harmful effect for risk factors including family history (OR: 1.80, 95%CI 1.47-2.12), hormonal replacement therapy (HRT) (OR: 5.48, 95%CI 0.84-1.74), passive smokers (OR: 1.68, 95%CI 1.34-2.03), full-term pregnancy at age 30 (OR: 3.41, 95%CI 1.19-5.63), abortion (OR: 1.84, 95%CI 1.35-2.33), sweets consumption (OR: 1.71, 95%CI 1.32-2.11) and genotype Arg/Arg (crude OR: 1.59, 95%CI 1.07-2.10), whereas a significant protective effect for late menarche (OR: 0.58, 95%CI 0.32-0.83), nulliparity (OR: 0.68, 95%CI 0.39-0.96), 13-24 months of breastfeeding (OR: 0.68, 95%CI 0.46-0.90), daily exercise (OR: 0.59, 95%CI 0.44-0.73) and vegetable consumption (crude OR: 0.28, 95%CI 0.10-0.46).

CONCLUSIONS

This study suggests that factors such as family history, HRT, passive smokers, late full-term pregnancy, abortion, sweets consumption and genotype Arg/Arg might increase risk of breast cancer development, whereas late menarche, nulliparity, 13-24 months breastfeeding, daily exercise and vegetable consumption had an inverse association with breast cancer development.

摘要

目的

乳腺癌是最致命的癌症之一,且其在全球范围内的发病率正在上升。目前已经确定了多种乳腺癌的确切和有争议的危险因素。本研究旨在对伊朗乳腺癌危险因素的流行病学进行系统回顾和荟萃分析。

方法

我们通过 PubMed、Scopus、Web of Science 和 Persian 数据库系统地检索了截至 2019 年 3 月发表的乳腺癌危险因素相关研究。对有多项研究报道的危险因素进行荟萃分析。我们使用固定/随机效应模型计算了相应的比值比(OR)及其 95%置信区间(CI)。

结果

共有 39 项研究纳入荟萃分析。汇总 OR 显示,家族史(OR:1.80,95%CI 1.47-2.12)、激素替代疗法(HRT)(OR:5.48,95%CI 0.84-1.74)、被动吸烟(OR:1.68,95%CI 1.34-2.03)、30 岁足月产(OR:3.41,95%CI 1.19-5.63)、流产(OR:1.84,95%CI 1.35-2.33)、甜食摄入(OR:1.71,95%CI 1.32-2.11)和基因型 Arg/Arg(未经校正 OR:1.59,95%CI 1.07-2.10)等危险因素与乳腺癌发病风险呈正相关,而月经初潮晚(OR:0.58,95%CI 0.32-0.83)、未婚(OR:0.68,95%CI 0.39-0.96)、哺乳 13-24 个月(OR:0.68,95%CI 0.46-0.90)、每日运动(OR:0.59,95%CI 0.44-0.73)和蔬菜摄入(未经校正 OR:0.28,95%CI 0.10-0.46)等因素与乳腺癌发病风险呈负相关。

结论

本研究表明,家族史、HRT、被动吸烟、足月晚产、流产、甜食摄入和基因型 Arg/Arg 等因素可能会增加乳腺癌发生的风险,而月经初潮晚、未婚、哺乳 13-24 个月、每日运动和蔬菜摄入与乳腺癌发生风险呈负相关。

相似文献

1
Breast cancer risk factors in Iran: a systematic review & meta-analysis.伊朗乳腺癌危险因素的系统评价和荟萃分析。
Horm Mol Biol Clin Investig. 2020 Oct 21;41(4):/j/hmbci.ahead-of-print/hmbci-2020-0021/hmbci-2020-0021.xml. doi: 10.1515/hmbci-2020-0021.
2
Breast cancer risk factors in Iranian women: a systematic review and meta-analysis of matched case-control studies.伊朗女性乳腺癌风险因素的系统评价和配对病例对照研究的荟萃分析。
Eur J Med Res. 2022 Dec 27;27(1):311. doi: 10.1186/s40001-022-00952-0.
3
Breast Cancer Risk From Modifiable and Non-Modifiable Risk Factors among Palestinian Women: A Systematic Review and Meta-Analysis.巴勒斯坦女性可改变和不可改变的乳腺癌风险因素:系统评价和荟萃分析。
Asian Pac J Cancer Prev. 2021 Jul 1;22(7):1987-1995. doi: 10.31557/APJCP.2021.22.7.1987.
4
Risk factors of breast cancer: a systematic review and meta-analysis.乳腺癌的风险因素:系统评价和荟萃分析。
Asia Pac J Public Health. 2013 Sep;25(5):368-87. doi: 10.1177/1010539513488795. Epub 2013 May 23.
5
Abortion and the risk of breast cancer: a case-control study in Greece.人工流产与乳腺癌风险:希腊的一项病例对照研究。
Int J Cancer. 1995 Apr 10;61(2):181-4. doi: 10.1002/ijc.2910610207.
6
Factors for the Primary Prevention of Breast Cancer: A Meta-Analysis of Prospective Cohort Studies.乳腺癌一级预防的因素:前瞻性队列研究的荟萃分析
J Res Health Sci. 2021 Jul 20;21(3):e00520. doi: 10.34172/jrhs.2021.57.
7
Risk factors of breast cancer in north of Iran: a case-control in Mazandaran Province.伊朗北部乳腺癌的风险因素:马赞德兰省的一项病例对照研究。
Asian Pac J Cancer Prev. 2007 Jul-Sep;8(3):395-8.
8
Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.生殖因素、绝经激素治疗与原发性肝癌风险:观察性研究的系统评价和剂量-反应荟萃分析。
Hum Reprod Update. 2016 Dec;23(1):126-138. doi: 10.1093/humupd/dmw037. Epub 2016 Sep 21.
9
Association between common risk factors and molecular subtypes in breast cancer patients.乳腺癌患者常见风险因素与分子亚型的相关性。
Breast. 2013 Jun;22(3):344-50. doi: 10.1016/j.breast.2012.08.005. Epub 2012 Sep 14.
10
Breastfeeding and breast cancer risk by receptor status--a systematic review and meta-analysis.按受体状态划分的母乳喂养与乳腺癌风险——一项系统评价和荟萃分析
Ann Oncol. 2015 Dec;26(12):2398-407. doi: 10.1093/annonc/mdv379. Epub 2015 Oct 26.

引用本文的文献

1
Perceived barriers to timely diagnosis among Iranian women diagnosed with advanced breast cancer: a qualitative study.伊朗晚期乳腺癌女性患者及时诊断的感知障碍:一项定性研究。
BMJ Open. 2025 Aug 16;15(8):e095826. doi: 10.1136/bmjopen-2024-095826.
2
A large-scale case-control study on the association between dietary fat quality indices and risk of breast cancer.一项关于膳食脂肪质量指数与乳腺癌风险之间关联的大规模病例对照研究。
Sci Rep. 2025 Jul 31;15(1):27963. doi: 10.1038/s41598-025-12395-8.
3
Breast cancer determinants in low- to upper-middle-income countries: an umbrella review of meta-analyses of observational studies and an urgent call for implementation science.
低收入至中高收入国家的乳腺癌决定因素:观察性研究的荟萃分析的综合评价及对实施科学的迫切呼吁
BMC Cancer. 2025 Jul 1;25(1):1096. doi: 10.1186/s12885-025-14499-w.
4
Risk Factors Associated with Breast Cancer among Women in Iraq: A Case-Control Study.伊拉克女性乳腺癌相关危险因素:一项病例对照研究。
Asian Pac J Cancer Prev. 2025 May 1;26(5):1701-1708. doi: 10.31557/APJCP.2025.26.5.1701.
5
The association between adiposity indices and the odds of breast cancer based on findings from a case control study.基于一项病例对照研究的结果,肥胖指数与乳腺癌发病几率之间的关联。
Sci Rep. 2025 May 22;15(1):17754. doi: 10.1038/s41598-025-02392-2.
6
A Scoping Review of 20 Years Breast Cancer Screening Programs in Iran.伊朗20年乳腺癌筛查项目的范围综述
Iran J Public Health. 2025 Jan;54(1):88-100. doi: 10.18502/ijph.v54i1.17577.
7
New Genetic Variations in RNA-binding Protein Gene and Breast Cancer Risk: A Case-Control Study.RNA结合蛋白基因的新遗传变异与乳腺癌风险:一项病例对照研究。
Asian Pac J Cancer Prev. 2025 Jan 1;26(1):137-145. doi: 10.31557/APJCP.2025.26.1.137.
8
Adverse pregnancy outcomes and multiple cancers risk in both mother and offspring: an umbrella review of systematic reviews with meta-analyses of observational studies.不良妊娠结局和母婴多种癌症风险:对观察性研究系统评价和荟萃分析的伞式综述。
BMC Med. 2024 Oct 11;22(1):454. doi: 10.1186/s12916-024-03680-w.
9
Evaluating the Impact of a Clinical Breast Examination Screening Program within the IraPEN Project.评估 IraPEN 项目中临床乳房检查筛查计划的影响。
Asian Pac J Cancer Prev. 2024 Sep 1;25(9):3151-3157. doi: 10.31557/APJCP.2024.25.9.3151.
10
Validity of self-assessment pubertal Tanner stages by realistic color images and Pubertal Development Scale in a longitudinal cohort study.在一项纵向队列研究中,通过逼真彩色图像和青春期发育量表进行自我评估青春期坦纳分期的有效性。
Front Pediatr. 2024 Jul 16;12:1380934. doi: 10.3389/fped.2024.1380934. eCollection 2024.